Diagnostic Method for Alzheimer’s from Sweden Becomes International Standard
Researchers at Gothenburg University have developed a reference method for standardized measurements that diagnose Alzheimer’s disease decades before symptoms appear. The method has now formally been classified as the international reference method, which means that it will be used as the standard in Alzheimer’s diagnostics worldwide. Beta amyloid protein is commonly found in the brain. […]
Read MoreLong-Acting Injectable Antipsychotic To Prevent Relapse in First Episode Schizophrenia
Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.” Patients with recent onset of schizophrenia (n=86) were randomized to receive long-acting injectable risperidone or oral […]
Read MorePreventive Neuroradiology in Brain Aging and Cognitive Decline
A new review published online in American Journal of Neuroradiology highlights the concept that cognitive decline can be identified early and prevented by applying quantitative brain imaging techniques. [More]
Read MoreInstitute of Medicine Report on Cognitive Aging
The Institute of Medicine has recently released a report entitled Cognitive Aging: Progress in Understanding and Opportunities for Action. This special report addresses “the emerging concept of cognitive aging, the importance of this issue for the nation’s public health, and actions the nation needs to take to better understand and maintain the cognitive health of […]
Read MoreMany Dementia Patients Never Screened
A study by researchers from the University of Michigan found that despite clear signs that their memory and cognitive abilities have diminished, more than half of seniors with these symptoms have not seen a doctor about them. The study, published in Neurology, documents a clear lack of clinical testing for seniors with signs of cognitive […]
Read MoreEarly Detection and Intervention in Psychosis Improves 10-Year Outcome
Early detection in first-episode psychosis confers advantages for negative, cognitive, and depressive symptoms after 1, 2, and 5 years, but longitudinal effects have been unknown. A new article published in the American Journal of Psychiatry investigated the differences in symptoms and recovery after 10 years between regional health care sectors with and without a comprehensive […]
Read More